AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2021
Jun 10, 2021
34491_dirs_2021-06-09_279ae8c0-b01e-41c9-9028-8e8f3eeef940.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-06-07
Reporting Person: List Alan (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-07 | Employee Stock Option (Right to Buy) | $11.34 | A | 134186 | Acquired | 2031-06-06 | Common Stock (134186) | Direct |
| 2021-06-07 | Restricted Stock Units | $ | A | 78090 | Acquired | Common Stock (78090) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on April 26, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.
F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3: The RSUs shall vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.